Despite highly effective HIV prevention drugs on the market, only a fraction of those at risk in the U.S. are taking them — or even know they're an option. It's called pre-exposure prophylaxis, or ...
By integrating HIV care with non-communicable disease prevention and care, healthcare systems can help people living with HIV ...
A trial of lenacapavir showed 100% protection against HIV infection. But cuts to foreign aid and criticism over its pricing put the brakes on a worldwide rollout. Elna Schütz asks if we’re now seeing ...
An oral HIV drug helped patients with center-involved diabetic macular edema achieve improvements in visual acuity, according ...
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among ...
A generation has passed since the world saw the peak in AIDS-related deaths. Those deaths — agonizing, from diseases or infections the body might otherwise fight off — sent loved ones into the streets ...
Pill burden decreases and antiretroviral regimens simplify for many of the participants who start lenacapavir.
Cutting-edge prevention drugs – hailed as being able to reduce new infections to zero – could see the end of the Aids ...
The U.S. just shipped two million doses of lenacapavir, a groundbreaking twice-a-year HIV-prevention injectable medication, ...
The US has started to provide doses of a Gilead HIV prevention drug to low-income countries, but the program will not include ...